尿道扩张术在治疗女性膀胱出口梗阻中的意义  

Clinical value of urethral dilation in treatment of female bladder outlet obstruction

作　　者：李保国[1] 王文生[1] 李鑫[1] 张铜[1] 薛建[1] 

机构地区：[1]北京市海淀医院(北京大学第三医院海淀院区)泌尿外科,100080

出　　处：《中国医师进修杂志》2016年第10期919-921,共3页Chinese Journal of Postgraduates of Medicine

摘　　要：目的：探讨尿道扩张术治疗女性膀胱出口梗阻的效果。方法选取女性膀胱出口梗阻患者35例，均应用α受体阻滞剂治疗无效，在局部麻醉下行尿道扩张术，每周1次，共12次。治疗前后分别测定国际前列腺症状评分（IPSS）、生命质量评分（QOL）及残余尿量。结果患者治疗后IPSS、QOL和残余尿量均较治疗前明显降低[（10.23±6.31）分比（21.41±3.71）分、（2.31±0.65）分比（5.43±0.60）分和（20.73±10.59）ml比（85.23±12.15）ml]，差异有统计学意义（P＜0.01）。结论尿道扩张术是α受体阻滞剂治疗无效的女性膀胱出口梗阻患者的有效治疗方法之一，可使一部分患者避免有创检查及手术，值得在门诊及基层医院推广。Objective To explore the clinical value of urethral dilation in treatment of female bladder outlet obstruction. Methods Thirty-five female bladder outlet obstruction patients were selected, and all the patients failed for more than 1 month inαreceptor blocker treatment. The patients underwent urethral dilation under local anaesthesia, once a week, for a total of 12 times. The international prostate symptom score （IPSS）, quality of life score （QOL） and residual urine volume before and after treatment were examined. Results The IPSS, QOL and residual urine volume after treatment were significantly lower than those before treatment： （10.23 ± 6.31） scores vs. （21.41 ± 3.71） scores, （2.31 ± 0.65） scores vs. （5.43 ± 0.60） scores and （20.73 ± 10.59） ml vs. （85.23 ± 12.15） ml, and there were statistical differences （P〈0.01）. Conclusions The urethral dilation is one of the effective treatments for female bladder outlet obstruction patients who fail in αreceptor blocker treatment. It can make a part of patients avoid invasive examination and surgery, and it is worth to be popularized in clinic and primary hospital.

关 键 词：尿道梗阻 扩张术 女(雌)性 回顾性研究 

分 类 号：R699.5[医药卫生—泌尿科学]